The University of Kansas Cancer Center
Meredith Cooper is an experienced healthcare professional with a strong background in oncology and clinical research. Currently serving as the Program Director of Strategic Initiatives and Program Director for the Hematologic Malignancies and Cellular Therapeutics Division at The University of Kansas Cancer Center since September 2015, Meredith Cooper manages oncology accreditations and collaborates with physicians and administrative leaders to uphold quality standards. Previous roles include Research Coordinator at the University of Kansas Medical Center, Clinical Data Coordinator at Quintiles, and Research Coordinator at Duke University Health System, where Meredith Cooper ensured compliance with regulatory requirements and managed research protocols. Meredith Cooper holds a Bachelor of Arts in Psychology from the University of Oklahoma, obtained in 2010.
The University of Kansas Cancer Center
1 followers
The University of Kansas Cancer Center is the region's only National Cancer Institute-designated comprehensive cancer center, and one of only 53 nationally. Our extraordinary, multidisciplinary team members work together to transform cancer research and clinical care, with the unified goal of achieving a cancer-free world. Our partnerships include cancer research and healthcare professionals associated with the University of Kansas Medical Center and The University of Kansas Health System in Kansas City, the University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, Stowers Institute for Medical Research, Children’s Mercy and members of Masonic Cancer Alliance. For more information on The University of Kansas Cancer Center's research and outreach programs and award-winning patient care, visit www.kucancercenter.org/. Follow us on social media: - Twitter:@KUCancerCenter - Instagram: @KUCancerCenter - Facebook:www.facebook.com/kucancercenter